Business
Definitive Healthcare Reports Financial Results for First Quarter 2026
First Quarter Revenue at Top End of GuidanceFRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, w
About this update from Definitive Healthcare Corp.
[{"type":"image","alt":"Definitive Healthcare Corp.","displaySize":"","headline":null,"caption":"Definitive Healthcare Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AN.bdhHyWLEBFsNyaGtv1g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1/https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de","width":300,"height":61}},"lazy":false},{"type":"text","content":"First Quarter Revenue at Top End of Guidance","length":44,"tagName":"p"},{"type":"text","content":"FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026.","length":268,"tagName":"p"},{"type":"text","content":"First Quarter 2026 Financial Highlights:","length":40,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025.","length":74,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":74,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue.","length":236,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":236,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted Net Income was $8.5 million, compared to $7.0 million in Q1 2025.","length":79,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":79,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted EBITDA was $15.3 million, or 27% of revenue, compared to $14.7 million, or 25% of revenue in Q1 2025.","length":115,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":115,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Cash Flow from Operations was $11.6 million in the quarter.","length":64,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":64,"olType":false},{"type":"...